Welcome to the Diabetes Trials Unit
The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit (#14), specialising in performing national and multinational clinical trials related to diabetes, and a member of the Medical Sciences Division Clinical Trials Sub-Committee.[More about the DTU]
To hear more about what it is like to take part in a diabetes research study watch our video
If you would like to take part in one of our studies or find out more, please complete our enquiry form.
REF2014 Impact Case Studies
The REF is a system for assessing the quality of research in UK higher education institutions implemented for the first time in 2014.[Read more]
DTU Director discusses EXSCEL18-Jan-2018
The Exenatide Study of Cardiovascular Event Lowering (EXSCEL) is a trial that assessed the long-term cardiovascular safety and efficacy of once-weekly exenatide, administered in patients with type 2 diabetes who had a wide range of cardiovascular risk. In this video, Professor Rury Holman shares his insights into the trial results.
ACP Journal Club review of EXSCEL12-Jan-2018
The ACP Journal Club has identified EXCSEL as an original study that warrants immediate attention by physicians attempting to keep pace with important advances in internal medicine.
[Click here to see review]
Update on EXSCEL presented at the 2017 IDF Congress09-Dec-2017
On Wednesday December 6th, Professor Angelyn Bethel presented new data from the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). The invited talk, presented within the "Latest Cardiovascular Clinical Trials" symposium, shared a new meta-analysis of the four glucagon-like peptide-1 receptor agonist cardiovascular outcome trials conducted to date....
New ACE data presented at the 2017 IDF Congress07-Dec-2017
A total of 7534 delegates from 182 countries attended the 2017 IDF Congress in Abu Dhabi.
On Wednesday 6th December, Professor Rury Holman gave an invited talk in the "Latest Cardiovascular Clinical Trials" symposium....